Original Article
Safety and efficacy of intranasal recombinant human interferon alfa 2b as prophylaxis for COVID-19 in patients on a hemodialysis program
Anselmo Abdo-Cuza 1 * 
, Roberto Castellanos-Gutiérrez 1 , Janete Treto-Ramirez 1, Sandra Arencibia-Larin 1 , Thalía Gómez-Pariente 1, Tania González-Fernández 1, Julio C. Hernández-Perera 1 , Katia Arocha-Stalella 1, Niurka Verdecia-Gorrita 1, Lisy Vento-Buigues 1, Yanet Cordero-Vasallo 1 , Yusmel Rivero-Yi 1, Odalys González-Dias 2, Hugo Nodarse-Cuni 2, Rafael Machado-Martínez 1 , Miguel A. Blanco-González 1 , Julio Valdivia-Arencibia 1, Daymiris Mendez-Felipe 1, Ernesto Delgado-Almora 1, Carlos Gutiérrez-Gutiérrez 1, Juliette Suárez-López 3 , Jorge L. Leiva-Torres 1, Alicia Rodríguez-Sotolongo 1, Nilda Bejerano-Gil 1